Kouper Launches with $10M Funding to Revolutionize Care Transitions in Healthcare
Kouper, a pioneering health technology platform, has announced its emergence from stealth mode with a substantial $10 million funding round led by General Catalyst, 25Madison, and CVS Health Ventures. This investment aims to support the millions of patients navigating transitions across various healthcare settings in the United States each year.
The significant challenge of managing patient care transitions—especially post-hospital discharge—can lead to over $50 billion in avoidable readmission costs annually. Kouper addresses this issue with an AI-driven infrastructure that enhances patient engagement and automates healthcare scheduling, streamlining the journey from emergency room visits to follow-up appointments.
By integrating directly with health systems, Kouper harnesses real-time data across the care continuum, providing a comprehensive view of the patient journey. Its platform aims to empower healthcare organizations to enhance their transitions of care programs effectively, bypassing the need for additional staff or complicated management processes. The implementation of Kouper can be achieved in as little as four weeks, leading to significant improvements in patient engagement and follow-up adherence.
“The journey through the American healthcare system is fraught with challenges… Our absolute focus is on creating a personalized transition of care experience for every patient,” said Salman Ali, Co-Founder and CEO of Kouper.
With endorsements from key industry leaders, including Chris Bischoff from General Catalyst and Merrill Anovick from 25Madison, Kouper is set to expand its influence within the healthcare landscape. Collaborative efforts with various health systems, including Ascension Saint Thomas, underscore its commitment to delivering timely follow-up care, marking a pivotal advancement in patient-centered healthcare technology.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
